• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酸奶中一种可降低人体胆固醇血症的因子。

A factor in yogurt which lowers cholesteremia in man.

作者信息

Mann G V

出版信息

Atherosclerosis. 1977 Mar;26(3):335-40. doi: 10.1016/0021-9150(77)90086-7.

DOI:10.1016/0021-9150(77)90086-7
PMID:849378
Abstract

Large dietary intakes of yogurt are found to lower cholestermia in man. This effect is associated with a reduction of incorporation of radioacetate into serum cholesterol. The effect appears slowly and persists after intake of the yogurt stops suggesting that the mechanism involves the synthesis of a regulatory protein rather than an allosteric effect. The effective agent is postulated to be hydroxymethyl glutarate which inhibits the regulatory enzyme hydroxymethyl glutaryl CoA reductase (EC 1.1.1.3.4).

摘要

研究发现,大量摄入酸奶可降低人体胆固醇水平。这种效应与放射性乙酸盐掺入血清胆固醇的减少有关。该效应出现缓慢,且在停止摄入酸奶后仍持续存在,这表明其机制涉及一种调节蛋白的合成,而非变构效应。据推测,有效成分是羟甲基戊二酸,它可抑制调节酶羟甲基戊二酰辅酶A还原酶(EC 1.1.1.3.4)。

相似文献

1
A factor in yogurt which lowers cholesteremia in man.酸奶中一种可降低人体胆固醇血症的因子。
Atherosclerosis. 1977 Mar;26(3):335-40. doi: 10.1016/0021-9150(77)90086-7.
2
A factor in milk which influences cholestermia in rats.牛奶中一种影响大鼠胆固醇血症的因素。
Atherosclerosis. 1977 Mar;26(3):363-7. doi: 10.1016/0021-9150(77)90089-2.
3
Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.响应胆固醇吸收抑制而选择性代偿性诱导肝脏HMG-CoA还原酶
Exp Biol Med (Maywood). 2006 May;231(5):559-65. doi: 10.1177/153537020623100510.
4
Regulation of hepatic hydroxy methyl glutarate - CoA reductase for controlling hypercholesterolemia in rats.调控肝脏羟甲基戊二酸单酰辅酶 A 还原酶以控制大鼠的高胆固醇血症。
Biomed Pharmacother. 2017 Nov;95:1242-1250. doi: 10.1016/j.biopha.2017.09.071. Epub 2017 Oct 6.
5
Cholesterol biosynthesis and 3-hydroxy-3-methyl-glutaryl coenzyme A reductase in cultured glial and neuronal cells. Regulation by lipoprotein and by certain free sterols.培养的神经胶质细胞和神经元细胞中的胆固醇生物合成及3-羟基-3-甲基戊二酰辅酶A还原酶。脂蛋白和某些游离固醇的调节作用。
Biochim Biophys Acta. 1977 Mar 25;486(3):408-20. doi: 10.1016/0005-2760(77)90090-x.
6
[The low cholesterol diet: a shot in the dark in hereditary hypercholesteremia? A debate].[低胆固醇饮食:遗传性高胆固醇血症的盲目尝试?一场辩论]
Tidsskr Nor Laegeforen. 1976 Jun 10;96(16):925-7.
7
Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase.洛伐他汀介导的G1期阻滞是通过抑制蛋白酶体实现的,与羟甲基戊二酰辅酶A还原酶无关。
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7797-802. doi: 10.1073/pnas.96.14.7797.
8
Plant stanol fatty acid esters inhibit cholesterol absorption and hepatic hydroxymethyl glutaryl coenzyme A reductase activity to reduce plasma levels in rabbits.植物甾烷醇脂肪酸酯可抑制兔体内胆固醇吸收及肝脏羟甲基戊二酰辅酶A还原酶活性,从而降低血浆水平。
Metabolism. 2001 Sep;50(9):1106-12. doi: 10.1053/meta.2001.25664.
9
Prevention of cold inactivation of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase by NADPH.
Biochim Biophys Acta. 1975 May 22;388(2):254-9. doi: 10.1016/0005-2760(75)90130-7.
10
A new type of familial hypercholesterolaemia.
Lancet. 1975 Oct 18;2(7938):737-40. doi: 10.1016/s0140-6736(75)90723-0.

引用本文的文献

1
Research Progress on the Mechanism of Action and Screening Methods of Probiotics for Lowering Blood Lipid Levels.益生菌降血脂作用机制及筛选方法的研究进展
Foods. 2025 Apr 30;14(9):1583. doi: 10.3390/foods14091583.
2
Effects of Probiotic Supplementation on Dyslipidemia in Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.补充益生菌对2型糖尿病血脂异常的影响:一项随机对照试验的荟萃分析
Foods. 2020 Oct 26;9(11):1540. doi: 10.3390/foods9111540.
3
Experimental support for the effects of a probiotic/digestive enzyme supplement on serum cholesterol concentrations and the intestinal microbiome.
益生菌/消化酶补充剂对血清胆固醇浓度和肠道微生物群影响的实验支持。
J Transl Med. 2016 Jun 22;14(1):184. doi: 10.1186/s12967-016-0945-2.
4
Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders.益生菌与益生元:代谢紊乱的现状与未来展望
Nutrients. 2016 Mar 18;8(3):173. doi: 10.3390/nu8030173.
5
A Randomized Double-blind Controlled Trial of Lactobacillus acidophilus Plus Bifidobacterium bifidum versus Placebo in Patients with Hypercholesterolemia.嗜酸乳杆菌加双歧杆菌与安慰剂治疗高胆固醇血症患者的随机双盲对照试验
J Clin Diagn Res. 2015 Mar;9(3):KC01-4. doi: 10.7860/JCDR/2015/11867.5728. Epub 2015 Mar 1.
6
Anti-mutagenic and immuno-stimulatory properties of lactic acid bacteria.乳酸菌的抗突变和免疫刺激特性。
World J Microbiol Biotechnol. 1995 May;11(3):294-8. doi: 10.1007/BF00367102.
7
Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases.降低胆固醇的益生菌作为代谢性疾病的潜在生物疗法。
Exp Diabetes Res. 2012;2012:902917. doi: 10.1155/2012/902917. Epub 2012 May 3.
8
Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.乳酸菌会影响血清胆固醇水平、有害粪便酶活性和粪便含水量。
Lipids Health Dis. 2009 Jun 11;8:21. doi: 10.1186/1476-511X-8-21.
9
Hypocholesterolemic and immunostimulatory effects of orally applied Enterococcus faecium M-74 in man.口服屎肠球菌M-74对人体的降胆固醇和免疫刺激作用。
Folia Microbiol (Praha). 1995;40(6):639-46. doi: 10.1007/BF02818522.
10
The ecological interdependence of diet and disease in tribal societies.部落社会中饮食与疾病的生态相互依存关系。
Yale J Biol Med. 1980 Jul-Aug;53(4):295-306.